COVID-19 Therapeutic Information

Antiviral Treatment

We’re bringing the latest on COVID-19 therapeutics to quickly get treatments to our underserved neighbors.

We’ve partnered with COVID-19 response experts across the country to help you learn the latest on therapeutics, explore treatment options, and identify the right medication for your patients. Use the toolkit below and learn more.

You can also explore clinical resources to launch a Test-to-Treat program in your area. Downloadable workflows, process maps, and communication tools make it easier to launch a program, so you can focus on what’s important, saving lives.


COVID-19 Response is Evolving

It’s important we stay ahead of the curve.

The U.S. Department of Health & Human Services Administration for Strategic Preparedness & Response (ASPR) leads the nation’s preparedness and response to public health emergencies. Derek Eisenor, MD, Medical Officer in ASPR’s Division of Clinical Development, provides an overview of COVID-19 therapeutic options for COVID-19 patients with mild to moderate symptoms.

Learn more about oral antivirals, intravenous antivirals, and a monoclonal antibody.


Therapeutic Information Toolkit


Choose a Topic to See Resources
This is all the resources.
There are 5 Resources Available.

drug comparison COVID-19 Drug Interactions  University of Liverpool
Drug Overview COVID-19 Outpatient Therapeutics​  John Openshaw, MD, COVID-19 Clinical Team Lead, California Department of Public Health
Drug Overview Lagevrio: Fact Sheet  Emergency Use Authorization (EUA) for Lagevrio, Distributed by Merch Sharpe & Dohme LLC. Revised: 6/2022
Drug Overview Paxlovid: Fact Sheet  Emergency use authorization for Paxlovid, Distributed by Pfizer Labs. Revised: 12/12/2021


Clinical Information

Download workflows and customizable communication tools to help you implement a Test to Treat program.

Learn More

COVID-19 Test to Treat Equity Grant Program Page

Return to the main CCI program page.

Main Page